文献速递腹部CT

基于双层光谱CT的临床-影像组学联合模型预测胃癌病理T4分期

A Clinical-Radiomic Combined Model based on Dual-Layer Spectral CT for Predicting Pathological T4 in Gastric Cancer.
PubMed 文献 · Acad Radiol · 2025-05-05

本研究回顾性纳入148例经手术证实的胃癌患者,术前接受双层光谱CT扫描,分为训练队列104例和测试队列44例。基于常规120 kV CT及双层光谱CT衍生光谱基图像提取影像组学特征,结合临床特征构建联合模型,训练队列AUC为0.906(95% CI,0.848-0.963),测试队列AUC为0.873。联合模型诊断效能优于主观图像判读及其他模型,列线图与pT4状态显著相关。

要点

  • 肿瘤CT厚度和血清CA19-9水平为pT4的独立预测因素。
  • 临床-影像组学联合模型训练队列AUC 0.906(95% CI,0.848-0.963),测试队列AUC 0.873。
  • 联合模型效能优于主观图像判读和其他模型,列线图与pT4状态显著相关。

核心结论

  • 将临床特征与常规CT及双层光谱CT衍生光谱基图像的影像组学特征整合,对胃癌患者pT4预测达到较高诊断准确度,该联合方法可能有助于治疗规划和患者管理。

研究设计与样本

  • 回顾性研究,纳入148例经手术证实的胃癌患者,术前接受双层光谱CT扫描,分为训练队列104例和测试队列44例;主观评估基于常规120 kV CT图像由两名阅片者完成;影像组学特征提取自常规120 kV CT及双层光谱CT衍生光谱基图像,包括虚拟单能图像(40 keV、70 keV、100 keV)、碘密度、有效原子序数和电子密度图像,覆盖动脉期和门静脉期;以手术病理为参考标准。

诊断标准与关键数值

  • 临床-影像组学联合模型预测pT4的AUC在训练队列为0.906(95% CI,0.848-0.963),在测试队列为0.873;肿瘤CT厚度和血清CA19-9水平被确定为独立预测因素。

临床应用与阅片要点

  • 联合模型在训练队列和测试队列的AUC分别为0.906(95% CI,0.848-0.963)和0.873,列线图与pT4状态显著相关,作者认为该联合方法可能有助于胃癌的治疗规划和患者管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This study aimed to develop and validate a dual-layer spectral CT based clinical-radiomic model for pre-treatment prediction of pathological T4 (pT4) in gastric cancer (GC) patients.

MATERIALS AND METHODS: This retrospective study included 148 surgically confirmed GC patients who underwent dual-layer spectral CT scanning before surgery and were divided into a training (n=104) and test (n=44) cohorts. Subjective assessments were performed based on conventional 120-kV CT images by two readers. Clinical models were developed using patient demographics, serum tumor markers, and image features from CT scans. Radiomics model included features extracted from conventional 120-kV CT and dual-layer CT-derived spectral base image (SBI), such as virtual monoenergetic images (40 keV, 70 keV, 100 keV), iodine density (ID), effective atomic number (Zeff), and electron density (ED) images for both the arterial phase (AP) and portal venous phase (PVP). A clinical-radiomic combined model was developed and visualized using a nomogram.

RESULTS: Tumor thickness on CT and serum level of CA19-9 levels were identified as independent predictors. The clinical-radiomic combined model demonstrated superior performance compared to subjective image interpretation and other models, with an AUC of 0.906 (95% CI, 0.848-0.963) in the training cohort and 0.873 in the test cohort. The nomogram was significantly associated with pT4 status, supporting its potential utility in clinical prediction.

CONCLUSION: The integration of clinical characteristics with radiomic features from conventional CT and dual-layer CT-derived SBI achieved a high diagnostic accuracy for predicting pT4 in GC patients. This combined approach could assist in treatment planning and patient management in GC.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zeng S, Yin S, Lian S, et al. A Clinical-Radiomic Combined Model based on Dual-Layer Spectral CT for Predicting Pathological T4 in Gastric Cancer. Acad Radiol. 2025. PMID: 40328540. doi:10.1016/j.acra.2025.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。